• Nie Znaleziono Wyników

Effect of short-term fasting on urinary excretion of primary lipid peroxidation products and on markers of oxidative DNA damage in healthy women.

N/A
N/A
Protected

Academic year: 2021

Share "Effect of short-term fasting on urinary excretion of primary lipid peroxidation products and on markers of oxidative DNA damage in healthy women."

Copied!
6
0
0

Pełen tekst

(1)

Effect of short-term fasting on urinary excretion of primary lipid peroxidation

products and on markers of oxidative DNA damage in healthy women

Kyoung-Ho Lee

1

, Helmut Bartsch

2

, Jagadeesan Nair

2

,

Dong-Ho Yoo

1

, Yun-Chul Hong

1

, Soo-Hun Cho

1

and

Daehee Kang

1,

1Department of Preventive Medicine, Seoul National University College

of Medicine, Institute for Environmental Medicine, SNUMRC, Seoul 110-799, Korea and2German Cancer Research Center (DKFZ),

Division of Toxicology and Cancer Risk Factors, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany

To whom correspondence should be addressed at: Department of

Preventive Medicine, Seoul National University College of Medicine, Institute of Environmental Medicine, SNUMRC, 28 Yongon-Dong Chongno-Gu, Seoul 110-799, Korea. Tel:+82 2 740 8326; Fax:+82 2 747 4830;

E-mail: dhkang@snu.ac.kr

The goal of this study was to determine whether

short-term fasting changes in urinary biomarkers

related to oxidative stress: malondialdehyde (MDA),

8-isoprostaglandin

F

2a

(8-isoPGF),

8-hydroxydeoxy-guanosine (8-OHdG) and 1,N

6

-ethenodeoxyadenosine

(edA) among female volunteers participating in the

short-term fasting program in South Korea. The study

subjects were 52 healthy women (mean age 28, range

15–48 years old) who provided urine samples both

before and after the fasting program (average 7.2,

range: 3–11 days). Urinary MDA was measured by

HPLC-UV and

edA levels were measured by

immuno-affinity purification followed by HPLC-fluorescence

detection. Urinary 8-OHdG and 8-isoPGF concentrations

were determined by ELISA. Plasma leptin levels were

also measured by radioimmunoassay. Information on

demographic characteristics, personal habits (smoking

and alcohol consumption) and previous medical history

were collected by a self-administered questionnaire.

Percent loss of body weight (average 6.3%, 4.28 ± 0.25

kg) was significantly correlated with fasting duration (r

¼

0.70, n

¼ 52, P < 0.01). The plasma leptin levels after

fasting (5.89 ± 1.10 ng/ml) were significantly lower than

before fasting (6.91 ± 1.13 ng/ml) (n

¼ 27, P ¼ 0.05).

Urinary MDA levels after fasting (0.18 ± 1.10 mg/g

creatinine) were significantly lower than before fasting

(0.37 ± 1.11) (n

¼ 51, P < 0.01). Urinary 8-isoPGF also

were significantly reduced after fasting (n

¼ 47, P < 0.01).

However, there was no significant difference in 8-OHdG

or

edA. There was a statistically significant correlation

between % change of urinary MDA level with % change

of

8-isoPGF

level

(partial

correlation

coefficient

r

¼ 0.57, n ¼ 46, P ¼ 0.01). The correlations between

% change of 8-OHdG and plasma leptin was also

signi-ficant (partial correlation coefficient r

¼ 0.51, n ¼ 27, P ¼

0.02). Our results demonstrate that the short-term fasting

reduces lipid peroxidation products but does not affect

oxidative stress-induced DNA damage.

Introduction

Obesity is related to increased morbidity and mortality of

cancer and cardiovascular disease which are two major

causes of deaths in the USA (1,2). Dietary restriction has

been shown to have several health benefits including

increased insulin sensitivity, stress resistance, reduced

morbidity and increased life span (3,4).

Fasting has been suggested to have beneficial effects on

glucose regulation and neuronal resistance to injury (4).

Short-term fasting has been shown to prolong the life

span of autoimmune-prone mice (5) and to reduce plasma

leptin concentration in dairy cattle, non-obese healthy

humans and sympathectomized men (6–9). A moderate

degree of short-term weight reduction significantly decreases

leptin levels in otherwise healthy overweight adults (10).

Although the underlying mechanism involved in the

bene-ficial effects of dietary restriction are not known, oxidative

stress has been proposed as an important intermediate event.

Caloric restriction can decrease oxidative DNA damage (11).

Caloric restricted C57BL/6 mice show a lower concentration

of 8-oxo-7,8-dihydro-2

0

-deoxyguanosine (8-OHdG), the

most widely studied markers of oxidative DNA damage

(12,13). Caloric restriction also reduces malondialdehyde

(MDA), a product of lipid peroxidation (LPO), in skeletal

muscles of Rhesus monkeys (14) but not in

streptozotocin-induced

diabetic

rats

(15,16).

8-Isoprostaglandin-F

2a

(8-isoPGF) is the prostaglandin-like compound produced

by non-enzymatic mechanism of peroxidation of lipoproteins

(17). It is chemically stable and can be measured in human

urine (18–19). Diet and exercise intervention can reduce

8-isoPGF levels and short-term weight loss is also associated

with significant reduction of 8-isoPGF (17,20).

Abbreviations:8-isoPGF, 8-isoprostaglandin-F2a; 8-OHdG,

8-oxo-7,8-dihydro-20-deoxyguanosine; ELISA, enzyme-linked immunosorbent assay;

LPO, lipid peroxidation; MDA, malondialdehyde; TBA, 2-thiobarbituric acid;edA, 1,N6-ethenodeoxyadenosine.

Advance Access publication January 9, 2006

 The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

(2)

1,N

6

-Ethenodeoxyadenosine (edA) is formed as stable DNA

base adducts from reactive aldehydes such as

trans-4-hydroxy-2-nonenal during oxidative stress or LPO (21). Urinary

edA as

a whole body marker for LPO has been reported to be

asso-ciated with salt-induced inflammation and

w-6 polyunsaturated

fatty acid intake in postmenopausal Japanese women (22).

The purpose of this study was to determine whether

short-term fasting changes urinary biomarkers related to

oxidative stress. The markers included in the study were

urinary MDA, 8-isoPGF, 8-OHdG and urinary

edA. The

sub-jects recruited for this study were healthy female volunteers

participating in a short-term fasting program.

Materials and methods

Materials

Methanol and acetonitrile were purchased from HAYMAN (Witham, Essex, UK) with a purity of 99.85%. 2-Thiobarbituric acid (TBA) and MDA standard were purchased from the Sigma–Aldrich Korea (Yongin, Kyunggi, Korea). The enzyme-linked immunosorbent assay (ELISA) kit for 8-isoPGF was obtained from OxisResearch (Portland, OR). The commercial ELISA kit for 8-OHdG was from the Japan Institute for the Control of Aging (Fukuroi, Shizuoka, Japan) designed for quantitative measurement of the oxidative DNA adduct 8-OHdG in urine. All other chemicals were obtained in the greatest purity available from commercial suppliers.

Study subjects

The study subjects consisted of 58 volunteers who participated in a fasting program (7.2 days, range: 3–11 days) and provided first morning void urine samples both before and after the fasting program in South Korea. Four males were excluded because of a small proportion (7%) and gender-specific differ-ences in the formation of certain biomarkers for oxidative stress (e.g. 8-isoPGF, edA) (23). Two females who did not complete the questionnaires were also excluded. Finally, 52 women remained in the study (mean age 28.3, range 15– 48 years old). Of these, only 30 people provided paired blood samples. All participants did not have food during the fasting program; however, water was permitted. Participants were allowed to do light exercise during the fasting program including jogging and yoga but strenuous physical activities (e.g. running, cycling, heavy weight lifting, tennis, soccer, etc.) were avoided. Every volunteer had a baseline physical examination. All participants were screened for diabetes, hypertension and other major systemic illnesses such as gastrointestinal disturbance, liver function and nephropathy. At the end of the fasting period, the volunteers started on liquids first and gradually changed to a regular diet. The study was approved by the institutional review board at the Seoul National University College of Medicine and each subject gave written informed consent. Information on demographic characteristics such as smoking, alcohol consumption, diet, medical history and medicine use was collected using a self-administered questionnaire.

Sample collection

Urine and blood samples were collected before and after the fasting. First morning urine samples were collected before the fasting program started and after the program ended. Urine samples were collected in 50 ml polypro-pylene tubes and stored at20C until analysis. Blood samples (5 ml) were

collected in EDTA vacutainer tubes and kept at80C until analysis.

Analysis of urinary MDA

MDA was measured using a method previously described (24) with minor modifications. The most common method of measuring MDA is based on the reaction with TBA. A 10 mmol/l stock standard of MDA was prepared by dissolving 123.5ml of 1,1,3,3-tetraethoxypropane in 50 ml of ethanol (40% ethanol by volume). TBA–MDA adducts were prepared in glass tubes with a polypropylene stopper. In each tube, 300ml of phosphoric acid (0.5 M) was mixed with 50ml of urine and 150 ml of TBA reagent. The mixtures were incubated at 95C for 1 h and methanol (500ml) was added in each tube.

Following a 5 min centrifugation (5000 g), the samples were analyzed using HPLC on a 4· 150 mm Xtera C18 column with UV (wavelengths, 532 nm). The mobile phase was potassium phosphate (0.05 mol/l; pH 6.8) and methanol (58:42, v/v). The flow rate was 0.8 ml/min.

Analysis of urinary 8-isoPGF

The urine samples were analyzed for 8-isoPGF levels by a competitive enzyme-linked immunoassay (ELISA) (25). This ELISA kit can be used for the quantitation of free 8-isoPGF in urine samples without the need for prior

purification or extraction. In brief, the samples were mixed with an enhancing reagent that essentially eliminates interference due to non-specific binding. Following substrate addition, the intensity of the color was noted to be inversely proportional to the amount of unconjugated 8-isoPGF in the sample or standard.

Analysis of urinary 8-OHdG

The level of urinary 8-OHdG was determined by a competitive enzyme-linked immunosorbent assay (ELISA) kit (JAICA, Fukuroi, Japan). In brief, 50ml of primary monoclonal antibody and a 50ml of sample or standard were added to microtiter plates, which were pre-coated with 8-OHdG, incubated at 37C

for 1 h and washed with 250ml of phosphate-buffered saline (PBS). One hundred microliters of HRP-conjugated secondary antibody was then added to each well, incubated at 37C for 1 h and washed with 250ml of PBS. One

hundred microliters of enzyme substrate was then added to each well, incub-ated at 37C for 1 h and the reaction was terminated with 100ml of 1 N

phosphoric acid. Absorbance of each well was read at 450 nm by a microplate reader (ELx808, Bio-Tek, Winooski, VT).

Analysis of urinaryedA

Urinary edA was analyzed according to a method published earlier (22). Two milliliters urine samples were spiked with an internal standard (1,N6

-ethenoadenosine-[2,8-3H]) and purified on preparative HPLC. Two fractions (internal standard andedA) were collected; the earlier eluted I.S. fraction was counted for recovery by liquid scintillation counter and theedA fraction was concentrated (overnight) in a speed-vac and then used for immuno-precipita-tion.

The immunoprecipitation of edA was performed in Tris–HCl buffer (10 mM Tris, pH 7.5, 140 mM NaCl, 3 mM NaN3) containing 1% BSA

and 0.1% rabbit IgG (Sigma–Aldrich, Schnelldorf, Germany) and a mono-clonal antibody EM-A-1 provided by Dr P. Lorenz and M. Rajewky (Institute for Cell Biology, University of Essen, Germany). The antigen–antibody com-plex was precipitated with saturated ammonium sulfate. The precipitate was washed andedA eluted using 50% methanol/water and later concentrated in a speed-vac. The pellets were analyzed by an HPLC-fluorescence detector (Hewlett Packard, Waldbronn, Germany). Using a linear gradient (NH4)3PO4, 17 mM, pH 5, buffer/methanol 9:1 to 8:2 in 30 min at a flow

rate of 1 ml/min. TheedA peak was detected at l excitation 230/l emission 410 nm and quantified by a standard curve using edA standard (Sigma– Aldrich). The detection limit of edA in this HPLC system was 5 fmol per injection.

Plasma leptin assay

Plasma leptin levels were measured by a radioimmunoassay using a commer-cially available kit for human leptin (catalogue no. HL-81K; Linco Research, St Louis, MO), as described previously (26).

Statistical methods

The paired t-test was used to compare group means (before and after fasting) of biomarkers. Pearson’s correlation coefficient was used to evaluate correla-tions among biomarkers. All statistical analyses were performed with the SPSS statistical package version 10.0 (SPSS, Chicago, IL). Statistical significance was defined as P< 0.05.

Results

Average body weight loss was 4.28 ± 0.25 kg of their initial

body weight (62.18 ± 1.51 kg) (Table I). The percent loss

of body weight (mean 6.3%) was significantly correlated

with fasting duration (days) (Pearson’s correlation r

¼ 0.70,

n

¼ 52, P < 0.01) (Figure 1).

The plasma leptin levels after fasting (5.89 ± 1.10 ng/ml)

were significantly lower than before fasting (6.91 ± 1.13 ng/ml)

(n

¼ 27, P ¼ 0.05 by paired t-test) (Table I and Figure 2).

Urinary MDA levels after fasting (0.18 ± 1.10 mg/g

creat-inine) were significantly lower than before fasting (0.37 ± 1.11)

(n

¼ 51, P < 0.01 by paired t-test) (Table I). Urinary 8-isoPGF

also was significantly reduced after fasting (n

¼ 47, P < 0.01).

However, there was no significant difference in 8-OHdG

or

edA (Table I). Although creatinine levels increased

(16%) after fasting, the results of biomarker levels before

and after creatinine adjustment remained unchanged (Table II).

(3)

There was a statistically significant correlation between

percent change of urinary MDA levels and percent change

of 8-isoPGF levels (partial correlation coefficient r

¼ 0.57,

n

¼ 46, P ¼ 0.01) after adjusting for BMI and smoking. There

was also a statistically significant correlation between percent

change of urinary 8-OHdG with percent change of plasma

leptin level (partial correlation coefficient r

¼ 0.51, n ¼ 27,

P

¼ 0.02) (Table III).

Discussion

There was a significant reduction of urinary biomarkers of

oxidative stress related to LPO (e.g. MDA, 8-isoPGF) after

short-term fasting (average 7 days). A plasma leptin level was

also significantly reduced after fasting. Short-term fasting

reduced both non-specific biomarkers of LPO (MDA) and a

marker for in vivo LPO (8-isoPGF) produced from arachidonic

acid by COX-independent non-enzymatic mechanisms.

How-ever, biomarkers that may reflect longer-term oxidative DNA

damage (e.g. 8-OHdG,

edA) were not observed to change after

short-term fasting.

Although obesity is associated with increased oxidative

stress in animal models and an increase in 8-isoPGF in

the obese Zucker rat, limited information in humans is

2 4 6 8 10 12

Duration of fasting (days)

0 2 4 6 8 10 12 Body w e ight c h a nge (% )

Fig. 1.Correlation of body weight change (%) and fasting duration (days) (Pearson’s correlation coefficient r¼ 0.70, n ¼ 52, P < 0.01).

Table III. Partial correlation coefficients among percent change of biomarkers [(before after fasting)/before fasting · 100]

MDA 8-isoPGF 8-OHdG edA Leptin

MDA 0.57a 0.36 0.01 0.10 8-isoPGF 0.34 0.22 0.31 8-OHdG 0.28 0.51b edA 0.09 a P< 0.01.

bP< 0.05, adjusted for percent change BMI and smoking status.

Table II. Concentration of urinary creatinine and biomarkers (before creatinine adjustment)

Biomarkers N Arithmetic mean Geometric mean

Before fasting After fasting Pa Before fasting After fasting Pb

Creatinine (mg/dl) 52 150.01 ± 11.00 174.28 ± 12.15 0.13 121.82 ± 1.11 151.46 ± 1.08 0.06 MDA (mmol/litre) 51 2.52 ± 0.28 1.47 ± 0.12 <0.01 2.04 ± 1.09 1.29 ± 1.07 <0.01 8-isoPGF (ng/ml) 47 16.43 ± 3.43 7.73 ± 1.53 <0.01 6.06 ± 1.26 3.06 ± 1.30 <0.01 8-OHdG (ng/ml) 50 26.40 ± 4.21 29.14 ± 4.19 0.76 10.55 ± 1.30 15.32 ± 1.24 0.21 edA (fmol/ml) 48 111.95 ± 18.68 88.32 ± 12.30 0.10 68.86 ± 1.16 60.74 ± 1.14 0.41 a

by Wilcoxon signed rank test.

bby paired t-test.

Table I. Means (±SE) and percent change of urinary biomarkers of oxidative stress (MDA, 8-isoPGF, 8-OHdG andedA) and plasma leptin level before and after fasting

Biomarkers N Arithmetic mean Geometric mean

Before fasting After fasting % Change Pa Before fasting After fasting % Change Pb

Body weight (kg) 52 63.01 ± 1.51 58.69 ± 1.41 6.8 <0.01 62.18 ± 1.02 57.90 ± 1.02 6.3 <0.01 MDA (mg/g Cr) 51c 0.50 ± 0.07 0.24 ± 0.03 52.0 <0.01 0.37 ± 1.11 0.18 ± 1.10 51.5 <0.01 8-isoPGF (mg/g Cr) 47c 9.93 ± 2.00 4.40 ± 0.80 55.7 <0.01 5.26 ± 1.18 2.04 ± 1.26 61.2 <0.01 8-OHdG (mg/g Cr) 50c 16.50 ± 2.26 15.75 ± 1.69 4.5 0.97 8.83 ± 1.22 10.02 ± 1.20 +13.6 0.61 edA (fmol/mmol Cr) 48c 6.39 ± 0.61 7.22 ± 1.13 +13.0 0.59 5.32 ± 1.09 5.24 ± 1.12 1.5 0.91 Leptin (ng/ml) 27 8.03 ± 0.76 6.68 ± 0.66 16.8 0.02 6.91 ± 1.13 5.89 ± 1.10 14.8 0.05

aby Wilcoxon signed rank test. b

by paired t-test.

c

(4)

available (27,28). Davi et al. (18) showed that women with

android obesity had higher levels of urinary 8-isoPGF than

non-obese women. They also observed a statistically

signific-ant reduction of urinary 8-isoPGF in 11 women with android

obesity (BMI

>28 and waist-hip ratio >0.86) who successfully

achieved weight loss in a short-term weight loss program (12

weeks) (18). Roberts et al. (20) reported a significant reduction

of serum 8-isoPGF in 11 men on a low-fat, high-fiber diet

combined with daily exercise for 45–60 min for 3 weeks.

Thompson et al. (29) also reported a 35% reduction in urinary

8-isoPGF in 28 women after 14 days of consuming an array of

fruits and vegetables. These findings of a lower level of urinary

8-isoPGF may result from reduced oxidative stress from the

diet and exercise intervention.

However, results of the association between caloric

restric-tion and MDA are limited and inconsistent. Although

Zainal et al. (14) reported that caloric restriction lowered

the concentrations of MDA in skeletal muscle in the Rhesus

monkey, Ugochukwu et al. (15) failed to show the effect of

dietary caloric restriction on reduction of plasma MDA in

streptozotocin-induced diabetic rats. In a human intervention

study, there was no significant change in urinary MDA

levels in 28 women after 14 days of consuming fruits and

vegetables (29). These inconsistencies might be due to

insens-itivity and non-specificity of urinary MDA and/or incomplete

control for other factors (e.g. other diets, physical activity,

etc.) which may affect MDA levels. However, the significant

correlation between the change of urinary 8-isoPGF and the

change of MDA during the fasting periods observed in this

study suggests that short-term fasting significantly reduced

oxidative stress, particularly generated by the short-term

LPO process.

On the contrary to a number of previous animal studies

showing significant reduction of oxidative DNA damage

after short-term caloric restriction (30–32), there was no

sig-nificant change in 8-OHdG or

edA levels in this study. The

Before After Ur in ar y M D A 0.0 0.2 0.4 0.6 0.8 1.0 1. A 2 Ur in ar y 8 -I so P G F 0 5 10 15 20 25 30 Before After U rin ar y 8 -O H d G 0 20 40 60 Before After Urinary εdA 0 5 10 15 Before After B C D

Fig. 2. Urinary biomarkers of oxidative stress before and after fasting (solid bar: the median; dotted bar: mean; whiskers: the minimum and maximum; boxes: the first and third quartiles; dot: outlier). A: Urinary MDA (mg/g creatinine), B: Urinary 8-IsoPGF (mg/g creatinine), C: Urinary 8-OHdG (mg/g creatinine), D: Urinary "dA (f mol/mmol creatinine)

(5)

finding of no significant reduction in urinary 8-OHdG levels

observed in this study is consistent with the findings from

28 women in a diet intervention program (29). Although the

finding of a significant correlation between the change in

urinary 8-OHdG with the change of plasma leptin levels

observed in this study may suggest the effect of short-term

fasting on urinary 8-OHdG levels, these results could be

explained by several other factors. First, short-term fasting

or severe caloric restriction may not alter the steady-state

level of oxidative DNA damage which is determined, in

part, by the rate of hydroxyl radical generation and individual

repair capacity.

edA which reflects longer-term oxidative DNA

damage may not be associated with short-term fasting or

severe caloric restriction (23). Second, we could not control

for other factors (e.g. inter-individual variation of

toxicokin-etics and/or repair capacity, hidden inflammatory process, etc.)

possibly related to oxidative DNA damage (8-OHdG,

edA)

levels. The study would have been strengthened by following

out for an additional time period after the restoration of the

normal diet.

Although our results may not have practical implications

because of the artificial nature of study design (fasting a few

days), recent biochemical and microarray results summarized

by Spindler (33) suggest that short-term caloric restriction acts

rapidly and reversibly to extend life span in animal model.

Furthermore, short-term caloric restriction (2 weeks)

signi-ficantly decreased cellular oxygen consumption and reactive

oxygen species production of rat muscle mitochondria (30).

However, the results of this study should be cautiously

interpreted and future studies of the effect of long-term fasting

should be conducted.

In conclusion, although the long-term effects of fasting

remain to be investigated, our results suggest that short-term

fasting exerts beneficial effects and reduces urinary levels

of primary LPO products (MDA, 8-isoPGF) without effecting

biomarkers of oxidative DNA damage (8-OHdG,

edA).

Acknowledgement

This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (02-PJ1-PG1-CH03-0001). Conflict of Interest Statement: None declared.

References

1. Calle,E.E., Rodriguez,C., Walker-Thurmond,K. and Thun,M.J. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med., 348, 1625–1638.

2. Calle,E.E. and Thun,M.J. (2004) Obesity and cancer. Oncogene, 23, 6365–6378.

3. Michels,K.B. and Ekbom,A. (2004) Caloric restriction and incidence of breast cancer. JAMA, 291, 1226–1230.

4. Anson,R.M., Guo,Z., de Cabo,R., Lyun,T., Rios,M., Hagepanos,A., Ingram,D.K., Lane,M.A. and Mattson,M.P. (2003) Intermittent fasting dis-sociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc. Natl Acad. Sci. USA, 100, 6216–6220.

5. Sogawa,H. and Kubo,C. (2000) Influence of short-term repeated fasting on the longevity of female (NZB· NZW) F1 mice. Mech. Ageing Dev., 115, 61–71.

6. Chelikani,P.K., Ambrose,J.D., Keisler,D.H. and Kennelly,J.J. (2004) Effect of short-term fasting on plasma concentrations of leptin and other hormones and metabolites in dairy cattle. Domest. Anim. Endocrinol., 26, 33–48.

7. Komaki,G., Matsumoto,Y., Nishikata,H., Kawai,K., Nozaki,T., Takii,M., Sogawa,H. and Kubo,C. (2001) Orexin-A and leptin change inversely in fasting non-obese subjects. Eur. J. Endocrinol., 144, 645–651.

8. Weigle,D.S., Duell,P.B., Connor,W.E., Steiner,R.A., Soules,M.R. and Kuijper,J.L. (1997) Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J. Clin. Endocrinol. Metab., 82, 561–565. 9. Jeon,J.Y., Harber,V.J. and Steadward,R.D. (2003) Leptin response to

short-term fasting in sympathectomized men: role of the SNS. Am. J. Phys-Endo. Meta., 284, 634–640.

10. Brook,R.D., Bard,R.L., Glazewski,L., Kehrer,C., Bodary,P.F., Eitzman,D.L. and Rajagopalan,S. (2004) Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults. Am. J. Cardiol., 93, 1012–1016.

11. Halliwell,B. (2002) Effect of diet on cancer development: is oxidative DNA damage a biomarker? Free Radic. Biol. Med., 32, 968–974. 12. Kasai,H. (1997) Analysis of a form of oxidative DNA damage,

8-hydroxy-20-deoxyguanosine, as a marker of cellular oxidative stress during

carcinogenesis. Mutat. Res., 387, 147–163.

13. Sohal,R.S., Agarwal,S., Candas,M., Forster,M.J. and Lal,H. (1994) Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice. Mech. Ageing Dev., 76, 215–224.

14. Zainal,T.A., Oberley,T.D., Allison,D.B., Szweda,L.I. and Weindruch,R. (2000) Caloric restriction of rhesus monkeys lowers oxidative damage in skeletal musle. FASEB J., 14, 1825–1836.

15. Ugochukwu,N.H., Bagayoko,N.D. and Antwi,M.E. (2004) The effects of dietary caloric restriction on antioxidant statue and lipid peroxidation in mild and severe streptozotocin-induced diabetic rats. Clin. Chim. Acta, 348, 121–129.

16. Lepage,G., Munoz,G., Champagne,J. and Roy,C.C. (1991) Preparative steps for the accurate measurement of malondialdehyde by high-perfor-mance liquid chromatography. Anal. Biochem., 197, 277–283.

17. Morrow,J.D. and Roberts,L.J. (1997) The isoprostanes: unique bioactive products of lipid peroxidation. Prog. Lipid Res., 36, 1–21.

18. Davi,G., Guagnano,M.T., Ciabattoni,G., Basili,S., Falco,A., Marinopiccoli,M., Nutini,M., Sensi,S. and Patrono,C. (2002) Platelet activation in obese women: role of inflammation and oxidant stress. JAMA, 288, 2008–2014.

19. Helmersson,J. and Basu,S. (2001) F(2)-isoprostane and prostaglandin F(2 alpha) metabolite excretion rate and day to day variation in healthy humans. Prostaglandins Leukot Essent Fatty Acids, 65, 99–102. 20. Roberts,C.K., Vaziri,N.D. and Barnard,R.J. (2002) Effect of diet and

exer-cise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation, 106, 2530–2532.

21. Nair,J., Barbin,A., Velic,I. and Bartsch,H. (1999) Etheno DNA-base adducts from endogenous reactive species. Mutat. Res., 424, 59–69. 22. Hanaoka,T., Nair,J., Takahashi,Y., Sasaki,S., Bartsch,H. and Tsugane,S.

(2002) Urinary level of 1,N(6) -ethenodeoxyadenosine, a marker of oxid-ative stress, is associated with salt excretion and omega 6-polyunsaturated fatty acid intake in postmenopausal Japanese women. Int. J. Cancer, 100, 71–75.

23. Nair,J., Vaca,C.E., Velic,I., Mutanen,M., Valsta,L.M. and Bartsch,H. (1997) High dietary omega-6 polyunsaturated fatty acids drastically increase the formation of etheno-DNA base adducts in white blood cells of female subjects. Cancer Epidemiol. Biomarkers Prev., 6, 597–601.

24. Hong,Y.C., Lee,K.H., Yi,C.H., Ha,E.H. and Christiani,D.C. (2002) Genetic susceptibility of term pregnant women to oxidative damage. Toxicol Lett., 129, 255–262.

25. Sasaki,D.M., Yuan,Y., Gikas,K., Kanai,K., Taber,D., Morrow,J.D., Roberts,L.J.II and Callewaert,D.M. (2002) Enzyme immunoassays for 15-F2T isoprostane-M, an urinary biomarker for oxidant stress.

Adv. Exp. Med. Biol., 507, 537–541.

26. Ma,Z., Gingerich,R.L., Santiago,J.V., Klein,S., Smith,C.H. and amd Landt,M. (1996) Radioimmunoassay of leptin in human plasma. Clin. Chem., 42, 942–946.

27. Laight,D.W., Desai,K.M., Gopaul,N.K., Anggard,E.E. and Carrier,M.J. (1999) F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E. Eur. J. Pharmacol., 377, 89–92.

28. Dobrian,A.D., Davies,M.J., Schriver,S.D., Lauterio,T.J. and Prewitt,R.L. (2001) Oxidative stress in a rat model of obesity-induced hypertension. Hypertension, 37, 554–560.

29. Thompson,H.J., Heimendinger,J., Haegele,A., Sedlacek,S.M., Gillette,C., O’Neill,C., Wolfe,P. and Conry,C. (1999) Effect of increased vegetable and fruit consumption on markers of oxidative cellular damage. Carcinogenesis, 20, 2261–2266.

(6)

30. Bevilacqua,L., Ramsey,J.J., Hagopian,K., Weindruch,R. and Harper,M.-E. (2004) Effect of short- and medium caloric restriction on muscle mitochon-drial proton leak and reactive oxygen species production. Am. J. Physiol. Endocrinol. Metab., 286, E852–E861.

31. Gredilla,R., Barja,G. and Lopez-Torres,M. (2001) Effect of short-term caloric restriction on H2O2production and oxidative damage in rat liver

mitochondria and location of the free radical source. J. Bioenerg. Biomembr., 33, 279–287.

32. Chung,M.H., Kasai,H., Nishimura,S. and Yu,B.P. (1992) Protection of DNA damage by dietary restriction. Free Radic. Biol. Med., 12, 523–525. 33. Spindler,S.R. (2005) Rapid and reversible induction of the longevity, anticancer and genomic effects of caloric restriction. Mech. Ageing Dev., 126, 960–966.

Received September 11, 2005; revised November 23, 2005; accepted January 3, 2006

Cytaty

Powiązane dokumenty

Wśród kobiet z NM zaobserwowano istotny związek między nasileniem objawów związanych z  popuszcza- niem moczu a jakością związku, która określana jest jako wymiar

Methods: The present study was a pilot study with 24 healthy volunteers and was designed to deter- mine if a 12-week administration of Cistus incanus herbal tea, containing

We wcześniejszym, przeprowadzonym przez autorów, badaniu oceniającym wpływ 25 mg spiro- nolaktonu na białkomocz i profil ciśnienia tętnicze- go u chorych z przewlekłym białkomoczem

ABSTRACT: The aim of this study was to investigate the effect of 12 weeks of aerobic training on the serum levels of adiponectin and leptin and on inflammatory markers of

Zadaniem dolnych dróg moczowych, w skład których wchodzą pęcherz i cewka moczowa wraz z aparatem zwieraczowym, jest gromadzenie moczu i jego zależne od woli

Rozpoznanie typu nietrzymania moczu u ka¿dej pacjentki ustalano na podstawie analizy danych uzyskanych z wywiadu, karty mikcyjnej, badania przedmiotowego (obejmuj¹cego badanie

Okres menopauzy, charakteryzuj¹cy siê spadkiem poziomu kr¹¿¹cych estrogenów, wi¹¿e siê ze wzrostem czêstoœci wystêpowania wysi³kowego nietrzymania moczu, paræ nagl¹- cych,

Powstawanie w efekcie takie- go b³êdnego ko³a stresu oksydacyjnego wydaje siê byæ szczególnie prawdopodobne we wczesnym okresie pooperacyjnym, kiedy nie s¹ w pe³ni